Drug Changes


Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.

To request Medicare Part D prescription drug coverage determinations (including tiering or formulary exception requests) please use the following form:



Oxbryta Tablet 500 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Hydroxyurea Capsule 500 MG Oral Tier 2 ST Antineoplastics, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Relyvrio Packet 3-1 GM Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Riluzole Tablet 50 MG Oral Tier 2 Central Nervous System, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Selzentry Tablet 25 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Maraviroc Tablet 150 MG Oral Tier 4 Anti-HIV Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Selzentry Tablet 75 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Maraviroc Tablet 150 MG Oral Tier 4 Anti-HIV Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 100 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 100 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 140 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 140 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 20 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 20 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 50 MG Oral


Post Date:
2/1/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 50 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 70 MG Oral


Post Date:
1/31/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 70 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 80 MG Oral


Post Date:
1/31/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 80 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tazorac Cream 0.05 % External


Post Date:
1/31/2025
Effective Date:
2/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tazarotene Cream 0.05 % External Tier 4 Acne and Rosacea Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Phenytoin Sodium Extended CAPSULE 200 MG ORAL


Post Date:
3/1/2025
Effective Date:
3/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Phenytek Capsule 200 MG Oral Tier 2 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Phenytoin Sodium Extended CAPSULE 300 MG ORAL


Post Date:
3/1/2025
Effective Date:
3/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Phenytek Capsule 300 MG Oral Tier 2 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Mesnex Tablet 400 MG Oral


Post Date:
3/31/2025
Effective Date:
4/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Mesna Tablet 400 MG Oral Tier 5 Treatment Adjuncts
* Please reference your Evidence of Coverage for applicable cost-sharing.

Spritam Tablet Disintegrating Soluble 250 MG Oral


Post Date:
3/31/2025
Effective Date:
4/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
levETIRAcetam Tablet Disintegrating Soluble 250 MG Oral Tier 4 PA Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Isosorbide Mononitrate Tablet 10 MG Oral


Post Date:
5/1/2025
Effective Date:
5/1/2025
Type of Change:
Cost sharing change
Reason Changed:
Cost sharing change
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Isosorbide Mononitrate Tablet 10 MG Oral Tier 3 Vasodilators, Direct-acting Arterial/ Venous
* Please reference your Evidence of Coverage for applicable cost-sharing.

Isosorbide Mononitrate Tablet 20 MG Oral


Post Date:
5/1/2025
Effective Date:
5/1/2025
Type of Change:
Cost sharing change
Reason Changed:
Cost sharing change
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Isosorbide Mononitrate Tablet 20 MG Oral Tier 3 Vasodilators, Direct-acting Arterial/ Venous
* Please reference your Evidence of Coverage for applicable cost-sharing.

Purixan Suspension 2000 MG/100ML Oral


Post Date:
6/1/2025
Effective Date:
6/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Mercaptopurine Suspension 2000 MG/100ML Oral Tier 5 Antimetabolites
* Please reference your Evidence of Coverage for applicable cost-sharing.

Brilinta Tablet 90 MG Oral


Post Date:
6/30/2025
Effective Date:
7/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Ticagrelor Tablet 90 MG Oral Tier 3 Platelet Modifying Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Libervant Film 10 MG Buccal


Post Date:
6/30/2025
Effective Date:
7/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Valtoco 10 MG Dose Liquid 10 MG/0.1ML Nasal Tier 4 QL Gamma-aminobutyric Acid (GABA) Modulating Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Libervant Film 12.5 MG Buccal


Post Date:
6/30/2025
Effective Date:
7/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Valtoco 15 MG Dose Liquid Therapy Pack 2 x 7.5 MG/0.1ML Nasal Tier 4 QL Gamma-aminobutyric Acid (GABA) Modulating Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Libervant Film 15 MG Buccal


Post Date:
6/30/2025
Effective Date:
7/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Valtoco 15 MG Dose Liquid Therapy Pack 2 x 7.5 MG/0.1ML Nasal Tier 4 QL Gamma-aminobutyric Acid (GABA) Modulating Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Libervant Film 5 MG Buccal


Post Date:
6/30/2025
Effective Date:
7/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Valtoco 5 MG Dose Liquid 5 MG/0.1ML Nasal Tier 4 QL Gamma-aminobutyric Acid (GABA) Modulating Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Libervant Film 7.5 MG Buccal


Post Date:
6/30/2025
Effective Date:
7/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Valtoco 10 MG Dose Liquid 10 MG/0.1ML Nasal Tier 4 QL Gamma-aminobutyric Acid (GABA) Modulating Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Aptiom Tablet 200 MG Oral


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Eslicarbazepine Acetate Tablet 200 MG Oral Tier 4 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Aptiom Tablet 400 MG Oral


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Eslicarbazepine Acetate Tablet 400 MG Oral Tier 5 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Aptiom Tablet 600 MG Oral


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Eslicarbazepine Acetate Tablet 600 MG Oral Tier 5 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Aptiom Tablet 800 MG Oral


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Eslicarbazepine Acetate Tablet 800 MG Oral Tier 5 Sodium Channel Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Brilinta Tablet 60 MG Oral


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Ticagrelor Tablet 60 MG Oral Tier 3 Platelet Modifying Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Dupixent Solution Prefilled Syringe 100 MG/0.67ML Subcutaneous


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
100 mg dose removed from market. Non-FRF and GPI is inactive.
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dupixent Solution Auto-Injector 300 MG/2ML Subcutaneous Tier 5 PA, QL Immunological Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Exelderm Cream 1 % External


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed
Reason Changed:
Removing from formulary as it is being promoted from non-FRF to FRF.
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Ciclopirox Solution 8 % External Tier 2 Topical Anti-infectives
* Please reference your Evidence of Coverage for applicable cost-sharing.

Lopinavir-Ritonavir Solution 400-100 MG/5ML Oral


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic demoted to non-FRF. Added brand to ensure access to oral solution
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Kaletra Solution 400-100 MG/5ML Oral Tier 4 Anti-HIV Agents, Protease Inhibitors (PI)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Retevmo Capsule 80 MG Oral


Post Date:
8/1/2025
Effective Date:
8/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Capsules being discontinued, replacing with tablets
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Retevmo Tablet 80 MG Oral Tier 5 PA, QL Antineoplastics, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Complera Tablet 200-25-300 MG Oral


Post Date:
9/1/2025
Effective Date:
9/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Emtricitab-Rilpivir-Tenofov DF Tablet 200-25-300 MG Oral Tier 5 QL Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Retevmo Capsule 40 MG Oral


Post Date:
9/1/2025
Effective Date:
9/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Retevmo Tablet 40 MG Oral Tier 5 PA, QL Antineoplastics, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Spritam Tablet Disintegrating Soluble 1000 MG Oral


Post Date:
9/1/2025
Effective Date:
9/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug strength discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Spritam Tablet Disintegrating Soluble 500 MG Oral Tier 4 PA Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Spritam Tablet Disintegrating Soluble 750 MG Oral


Post Date:
9/1/2025
Effective Date:
9/1/2025
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug strength discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Spritam Tablet Disintegrating Soluble 500 MG Oral Tier 4 PA Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tasigna Capsule 150 MG Oral


Post Date:
9/1/2025
Effective Date:
9/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Nilotinib HCl Capsule 150 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tasigna Capsule 200 MG Oral


Post Date:
9/1/2025
Effective Date:
9/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Nilotinib HCl Capsule 200 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tasigna Capsule 50 MG Oral


Post Date:
9/1/2025
Effective Date:
9/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Nilotinib HCl Capsule 50 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Bronchitol Capsule 40 MG Inhalation


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Cost sharing change
Reason Changed:
This was changed to Part D NO
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
1st Tier Unifine Pentips 33G X 4 MM Tier 3 Miscellaneous Therapies (Non-FRF Drugs)
Pulmozyme Solution 2.5 MG/2.5ML Inhalation Tier 5 PA Cystic Fibrosis Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Entresto Tablet 24-26 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Sacubitril-Valsartan Tablet 24-26 MG Oral Tier 2 Cardiovascular Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Entresto Tablet 49-51 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Sacubitril-Valsartan Tablet 49-51 MG Oral Tier 2 Cardiovascular Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Entresto Tablet 97-103 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Sacubitril-Valsartan Tablet 97-103 MG Oral Tier 2 Cardiovascular Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Fycompa Tablet 10 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Perampanel Tablet 10 MG Oral Tier 4 Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Fycompa Tablet 12 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Perampanel Tablet 12 MG Oral Tier 4 Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Fycompa Tablet 2 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Perampanel Tablet 2 MG Oral Tier 4 Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Fycompa Tablet 4 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Perampanel Tablet 4 MG Oral Tier 4 Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Fycompa Tablet 6 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Perampanel Tablet 6 MG Oral Tier 4 Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Fycompa Tablet 8 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Perampanel Tablet 8 MG Oral Tier 4 Anticonvulsants, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Ixchiq Solution Reconstituted Intramuscular


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Vimkunya Suspension Prefilled Syringe 40 MCG/0.8ML Intramuscular Tier 3 Vaccines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Jynarque Tablet 15 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tolvaptan Tablet 15 MG Oral Tier 5 PA Electrolyte/Mineral/Metal Modifiers
* Please reference your Evidence of Coverage for applicable cost-sharing.

Jynarque Tablet 30 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tolvaptan Tablet 30 MG Oral Tier 5 PA Electrolyte/Mineral/Metal Modifiers
* Please reference your Evidence of Coverage for applicable cost-sharing.

Kiprofen Capsule 25 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Removing NDC 73352050410 but maintaining coverage of GPI
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Ketoprofen Capsule 25 MG Oral Tier 2 Nonsteroidal Anti-inflammatory Drugs
* Please reference your Evidence of Coverage for applicable cost-sharing.

Norethindron-Ethinyl Estrad-Fe Tablet 1-20/1-30/1-35 MG-MCG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Removing NDC 00378730353, but maintaining coverage of GPI
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tri-Legest Fe TABLET 1-20/1-30/1-35 MG-MCG ORAL Tier 2 Hormonal Agents, Stimulant/ Replacement/ Modifying (Sex Hormones/ Modifiers)
* Please reference your Evidence of Coverage for applicable cost-sharing.

prednisoLONE Sodium Phosphate Tablet Dispersible 10 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Orapred ODT Tablet Dispersible 10 MG Oral Tier 4 Glucocorticoids
* Please reference your Evidence of Coverage for applicable cost-sharing.

prednisoLONE Sodium Phosphate Tablet Dispersible 15 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Orapred ODT Tablet Dispersible 15 MG Oral Tier 4 Glucocorticoids
* Please reference your Evidence of Coverage for applicable cost-sharing.

prednisoLONE Sodium Phosphate Tablet Dispersible 30 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Orapred ODT Tablet Dispersible 30 MG Oral Tier 4 Glucocorticoids
* Please reference your Evidence of Coverage for applicable cost-sharing.

Trecator Tablet 250 MG Oral


Post Date:
10/1/2025
Effective Date:
10/1/2025
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
levoFLOXacin Tablet 750 MG Oral Tier 2 Quinolones
* Please reference your Evidence of Coverage for applicable cost-sharing.


There are currently no changes for 2026